These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17599323)

  • 21. [Effect of recombinant human interleukin 11 on the platelet after hematopoietic stem cell transplantation in patients with leukemia].
    Xu YJ; Chen FP; Li XL; Zhao XL; He Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):433-6. PubMed ID: 17611320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
    Webert KE; Cook RJ; Couban S; Carruthers J; Lee KA; Blajchman MA; Lipton JH; Brandwein JM; Heddle NM
    Transfusion; 2008 Jan; 48(1):81-91. PubMed ID: 17894791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.
    Giebel S; Labopin M; Holowiecki J; Labar B; Komarnicki M; Koza V; Masszi T; Mistrik M; Lange A; Hellmann A; Vitek A; Pretnar J; Mayer J; Rzepecki P; Indrak K; Wiktor-Jedrzejczak W; Wojnar J; Krawczyk-Kulis M; Kyrcz-Krzemien S; Rocha V
    Ann Hematol; 2009 Oct; 88(10):1005-13. PubMed ID: 19301005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-related late-onset hemorrhagic cystitis post allogeneic hematopoietic stem cell transplantation.
    Huang XJ; Liu DH; Xu LP; Zhang HY; Liu KY
    Chin Med J (Engl); 2008 Sep; 121(18):1766-9. PubMed ID: 19080354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.
    Cordonnier C; Labopin M; Chesnel V; Ribaud P; De La Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Einsele H; Niederwieser D; Apperley J; Ljungman P;
    Clin Infect Dis; 2009 May; 48(10):1392-401. PubMed ID: 19368505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications for hematopoietic cell transplantation in acute leukemia.
    Davies SM; Rowe JM; Appelbaum FR
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):154-64. PubMed ID: 18162237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutritional assessment during allogeneic hematopoietic stem cell transplantation: single centre experience.
    Rzepecki R; Barzal J; Sarosiek T; Oborska S; Szczylik C
    J BUON; 2007; 12(2):253-9. PubMed ID: 17600881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prediction of T-cell immune reconstitution by investigating T cell receptor excision circle and T-cell receptor beta-chain variable region clonal repertoire in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Cen JN; Feng YF; Chang WR; Qiu QC; Zhu ZL; Zhu P
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2265-7. PubMed ID: 18001548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction of celiac disease after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kline RM; Neudorf SM; Baron HI
    Pediatrics; 2007 Oct; 120(4):e1120-2. PubMed ID: 17893186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of solitary plasmacytoma in the internal auditory canal and inner ear after allogeneic hematopoietic stem cell transplantation for plasma cell leukemia.
    Masuda M; Inoue Y; Tanosaki R; Kanzaki S; Ogawa K
    Jpn J Clin Oncol; 2007 Sep; 37(9):701-3. PubMed ID: 17673474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.
    van Kempen-Harteveld ML; Brand R; Kal HB; Verdonck LF; Hofman P; Schattenberg AV; van der Maazen RW; Cornelissen JJ; Eijkenboom WM; van der Lelie JP; Oldenburger F; Barge RM; van Biezen A; Vossen JM; Noordijk EM; Struikmans H
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1444-54. PubMed ID: 18294781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.
    Hadjibabaie M; Alimoghaddam K; Shamshiri AR; Iravani M; Bahar B; Mousavi A; Jahani M; Khodabandeh A; Anvari Y; Gholami K; Ghavamzadeh A
    Urol Oncol; 2008; 26(1):43-6. PubMed ID: 18190829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy and toxicity of intravenous busulfan-based conditioning before allogeneic peripheral blood stem cell transplantation for leukemia].
    Tong XZ; Xu DR; Zou WY; Li J; Luo SK; Peng AH; Zhang GC; Zheng D
    Ai Zheng; 2007 Aug; 26(8):914-8. PubMed ID: 17697559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
    Alousi A; de Lima M
    Clin Adv Hematol Oncol; 2007 Jul; 5(7):560-70. PubMed ID: 17679930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The haploidentical option for high-risk haematological malignancies.
    Aversa F; Reisner Y; Martelli MF
    Blood Cells Mol Dis; 2008; 40(1):8-12. PubMed ID: 17905610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.
    Maruyama D; Fukuda T; Kato R; Yamasaki S; Usui E; Morita-Hoshi Y; Kim SW; Mori S; Heike Y; Makimoto A; Tajima K; Tanosaki R; Tobinai K; Takaue Y
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):932-41. PubMed ID: 17640597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.